Hyperuricemia Independently Predicts Mortality Risk in Chronic Kidney Disease

A new study published in the Journal of Clinical Medicine reveals that hyperuricemia—elevated uric acid levels in the blood—independently predicts mortality risk in patients with chronic kidney disease (CKD). This finding is significant because it identifies uric acid as an independent risk factor separate from other known mortality predictors in CKD patients. The research highlights the importance of monitoring and managing uric acid levels in individuals with kidney disease. Healthcare providers may need to consider uric acid management as part of comprehensive treatment strategies to improve survival outcomes in CKD patients.

Originally published on
Medical Xpress
Read full article(opens in new tab)Fetched: August 1, 2026 at 10:02 AM



